Skip Navigation LinksHome > April 2011 - Volume 11 - Issue 2 > Airway molecular phenotypes in pediatric asthma
Current Opinion in Allergy & Clinical Immunology:
doi: 10.1097/ACI.0b013e328344874d
Pediatric asthma and development of atopy: Edited by Carlos E. Baena-Cagnani and Leonard B. Bacharier

Airway molecular phenotypes in pediatric asthma

Aujla, Shean J; Ross, Kristie R; Chmiel, James F; Holguin, Fernando

Collapse Box


Purpose of review: The review discusses what is known regarding airway molecular phenotypes in pediatric asthma, specifically biomarkers that have been studied and their relation to the various clinical phenotypes of asthma.

Recent findings: Pediatric asthma is a complex and heterogeneous disease that consists of several clinical phenotypes. There have been numerous studies investigating inflammatory markers that would increase our understanding of the underlying pathogenesis of asthma as well as facilitate the discovery of therapies for these patients. Some of these biomarkers, such as exhaled nitric oxide, exhaled breath condensate, urine leukotriene E4 and induced sputum are less invasive measures of inflammation than obtaining bronchoalveolar lavage fluid in children. Although recent data reveal that some of these measures may be helpful in classifying and managing pediatric asthma, further studies are critically needed before any of these biomarkers are able to be routinely used in clinical asthma care.

Summary: The search for noninvasive biomarkers to help elucidate specific underlying molecular phenotypes in pediatric asthma should be a continued priority as we work towards improved care and management of these children.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.